Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-24-073772

Options or other derivatives

  • Chief Executive Officer acquired 517,454 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Gros David-Alexandre C Chief Executive Officer 2024-06-13 Grant or award · Stock Option (right to buy) +517,454 517,454 D
Loading xslF345X05/ownership.xml…